At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
Dietary: saccharin +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intestinal Sweet Taste Receptor Function and Adaptation to Dietary Sugars and Sweeteners
AdventHealth Translational Research Institute·interventional·Posted Jul 18, 2016·Updated Aug 14, 2020
In Brief
A clinical study evaluating Dietary: saccharin and Estimate glucose absorptions for Diabetes. Completed, enrolled 10 participants across 1 site.
Detailed Summary
The purpose of this study is to collect data that will help researchers better understand the various causes of obesity and diabetes; particularly to understand how consumption of NCASs affects the way the body uses nutrients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesUnited States
CollaboratorsSanford-Burnham Medical Research Institute
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartAug 2014
Primary CompletionJan 2016
First PostedJul 2016
Study CompletionSep 2017
TodayJul 2026
First PostedJul 18, 2016
Enrollment StartAug 1, 2014
Primary CompletionJan 1, 2016
Study CompletionSep 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.0 years ago
Interventions
Dietary: saccharinother
Assess the glycemic and hormonal responses to an oral glucose load preceded by an oral solution of NCASs (saccharin).
Estimate glucose absorptionsother
Indirectly estimate the rate of glucose absorption and gastric emptying by using 3-O-methyglucose (3-OMG) and acetaminophen, respectively.